BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

745 related articles for article (PubMed ID: 28559081)

  • 1. Stemness Marker Detection in the Periphery of Glioblastoma and Ability of Glioblastoma to Generate Glioma Stem Cells: Clinical Correlations.
    Raysi Dehcordi S; Ricci A; Di Vitantonio H; De Paulis D; Luzzi S; Palumbo P; Cinque B; Tempesta D; Coletti G; Cipolloni G; Cifone MG; Galzio R
    World Neurosurg; 2017 Sep; 105():895-905. PubMed ID: 28559081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunophenotypic characterization of human glioblastoma stem cells: correlation with clinical outcome.
    Miconi G; Palumbo P; Dehcordi SR; La Torre C; Lombardi F; Evtoski Z; Cimini AM; Galzio R; Cifone MG; Cinque B
    J Cell Biochem; 2015 May; 116(5):864-76. PubMed ID: 25559650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells.
    Talukdar S; Das SK; Pradhan AK; Emdad L; Shen XN; Windle JJ; Sarkar D; Fisher PB
    Oncotarget; 2016 Aug; 7(34):54102-54119. PubMed ID: 27472461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoids promote a glioma stem cell-like phenotype and resistance to chemotherapy in human glioblastoma primary cells: Biological and prognostic significance.
    Kostopoulou ON; Mohammad AA; Bartek J; Winter J; Jung M; Stragliotto G; Söderberg-Nauclér C; Landázuri N
    Int J Cancer; 2018 Mar; 142(6):1266-1276. PubMed ID: 29067692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
    Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
    J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QKI deficiency maintains glioma stem cell stemness by activating the SHH/GLI1 signaling pathway.
    Han B; Wang R; Chen Y; Meng X; Wu P; Li Z; Duan C; Li Q; Li Y; Zhao S; Jiang C; Cai J
    Cell Oncol (Dordr); 2019 Dec; 42(6):801-813. PubMed ID: 31292920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xihuang Pill-destabilized CD133/EGFR/Akt/mTOR cascade reduces stemness enrichment of glioblastoma via the down-regulation of SOX2.
    Xu L; Duan H; Zou Y; Wang J; Liu H; Wang W; Zhu X; Chen J; Zhu C; Yin Z; Zhao X; Wang Q
    Phytomedicine; 2023 Jun; 114():154764. PubMed ID: 36963368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
    Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
    Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autocrine/paracrine sphingosine-1-phosphate fuels proliferative and stemness qualities of glioblastoma stem cells.
    Marfia G; Campanella R; Navone SE; Di Vito C; Riccitelli E; Hadi LA; Bornati A; de Rezende G; Giussani P; Tringali C; Viani P; Rampini P; Alessandri G; Parati E; Riboni L
    Glia; 2014 Dec; 62(12):1968-81. PubMed ID: 25042636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in Glioblastoma.
    Soroceanu L; Matlaf L; Khan S; Akhavan A; Singer E; Bezrookove V; Decker S; Ghanny S; Hadaczek P; Bengtsson H; Ohlfest J; Luciani-Torres MG; Harkins L; Perry A; Guo H; Soteropoulos P; Cobbs CS
    Cancer Res; 2015 Aug; 75(15):3065-76. PubMed ID: 26239477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NOS2 expression in glioma cell lines and glioma primary cell cultures: correlation with neurosphere generation and SOX-2 expression.
    Palumbo P; Miconi G; Cinque B; Lombardi F; La Torre C; Dehcordi SR; Galzio R; Cimini A; Giordano A; Cifone MG
    Oncotarget; 2017 Apr; 8(15):25582-25598. PubMed ID: 28424427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioma Cells in the Tumor Periphery Have a Stem Cell Phenotype.
    Munthe S; Petterson SA; Dahlrot RH; Poulsen FR; Hansen S; Kristensen BW
    PLoS One; 2016; 11(5):e0155106. PubMed ID: 27171431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indoleamine 2,3-dioxygenase 1 is highly expressed in glioma stem cells.
    Ozawa Y; Yamamuro S; Sano E; Tatsuoka J; Hanashima Y; Yoshimura S; Sumi K; Hara H; Nakayama T; Suzuki Y; Yoshino A
    Biochem Biophys Res Commun; 2020 Apr; 524(3):723-729. PubMed ID: 32035622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence.
    Auffinger B; Spencer D; Pytel P; Ahmed AU; Lesniak MS
    Expert Rev Neurother; 2015; 15(7):741-52. PubMed ID: 26027432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversing glioma malignancy: a new look at the role of antidepressant drugs as adjuvant therapy for glioblastoma multiforme.
    Bielecka-Wajdman AM; Lesiak M; Ludyga T; Sieroń A; Obuchowicz E
    Cancer Chemother Pharmacol; 2017 Jun; 79(6):1249-1256. PubMed ID: 28500556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suberoylanilide hydroxamic acid represses glioma stem-like cells.
    Hsu CC; Chang WC; Hsu TI; Liu JJ; Yeh SH; Wang JY; Liou JP; Ko CY; Chang KY; Chuang JY
    J Biomed Sci; 2016 Nov; 23(1):81. PubMed ID: 27863490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pterostilbene suppressed irradiation-resistant glioma stem cells by modulating GRP78/miR-205 axis.
    Huynh TT; Lin CM; Lee WH; Wu AT; Lin YK; Lin YF; Yeh CT; Wang LS
    J Nutr Biochem; 2015 May; 26(5):466-75. PubMed ID: 25736407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A ketogenic diet attenuates proliferation and stemness of glioma stem‑like cells by altering metabolism resulting in increased ROS production.
    Ji CC; Hu YY; Cheng G; Liang L; Gao B; Ren YP; Liu JT; Cao XL; Zheng MH; Li SZ; Wan F; Han H; Fei Z
    Int J Oncol; 2020 Feb; 56(2):606-617. PubMed ID: 31894296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma.
    Jiang W; Finniss S; Cazacu S; Xiang C; Brodie Z; Mikkelsen T; Poisson L; Shackelford DB; Brodie C
    Oncotarget; 2016 Aug; 7(35):56456-56470. PubMed ID: 27486821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDM2 Degrades Deacetylated Nucleolin Through Ubiquitination to Promote Glioma Stem-Like Cell Enrichment for Chemotherapeutic Resistance.
    Ko CY; Lin CH; Chuang JY; Chang WC; Hsu TI
    Mol Neurobiol; 2018 Apr; 55(4):3211-3223. PubMed ID: 28478507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.